4.6 Article

ADAM9 is highly expressed in renal cell cancer and is associated with tumour progression

Related references

Note: Only part of the references are listed.
Article Biochemistry & Molecular Biology

In search of suitable reference genes for gene expression studies of human renal cell carcinoma by real-time PCR

Monika Jung et al.

BMC MOLECULAR BIOLOGY (2007)

Review Oncology

Renal cell carcinoma

W. Kimryn Rathmell et al.

CURRENT OPINION IN ONCOLOGY (2007)

Article Urology & Nephrology

Impact of clinicopathological parameters in patients treated for renal cell carcinoma

Marcos F. Dall'Oglio et al.

JOURNAL OF UROLOGY (2007)

Article Biochemistry & Molecular Biology

The RIN: an RNA integrity number for assigning integrity values to RNA measurements

A Schroeder et al.

BMC MOLECULAR BIOLOGY (2006)

Review Genetics & Heredity

Epidermal growth factor receptor (EGFR) signaling in cancer

N Normanno et al.

Review Environmental Sciences

Current trends in the molecular classification of renal neoplasms

Andrew N. Young et al.

THESCIENTIFICWORLDJOURNAL (2006)

Article Oncology

Critical function for ADAM9 in mouse prostate cancer

L Peduto et al.

CANCER RESEARCH (2005)

Article Oncology

ADAM-9 expression and regulation in human skin melanoma and melanoma cell lines

P Zigrino et al.

INTERNATIONAL JOURNAL OF CANCER (2005)

Article Biochemistry & Molecular Biology

ADAM-mediated ectodomain shedding of HB-EGF in receptor cross-talk

S Higashiyama et al.

BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2005)

Review Pharmacology & Pharmacy

The ErbB receptors and their ligands in cancer: An overview

N Normanno et al.

CURRENT DRUG TARGETS (2005)

Article Biochemistry & Molecular Biology

The disintegrin domain of ADAM9:: a ligand for multiple β1 renal integrins

RM Mahimkar et al.

BIOCHEMICAL JOURNAL (2005)

Article Gastroenterology & Hepatology

Gene expression analysis of pancreatic cell lines reveals genes overexpressed in pancreatic cancer

I Alldinger et al.

PANCREATOLOGY (2005)

Article Oncology

Increased expression of ADAM family members in human breast cancer and breast cancer cell lines

U Lendeckel et al.

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2005)

Article Gastroenterology & Hepatology

ADAM17 mRNA expression and pathological features of hepatocellular carcinoma

Xiang Ding et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2004)

Article Gastroenterology & Hepatology

The mechanism of cleavage of EGFR ligands induced by inflammatory cytokines in gastric cancer cells

S Tanida et al.

GASTROENTEROLOGY (2004)

Article Biochemistry & Molecular Biology

ADAM binding protein Eve-1 is required for ectodomain shedding of epidermal growth factor receptor ligands

M Tanaka et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2004)

Article Oncology

Expression of ADAM-9 mRNA and protein in human breast cancer

C O'Shea et al.

INTERNATIONAL JOURNAL OF CANCER (2003)

Article Pathology

The expression of ADAM12 (meltrin α) in human giant cell tumours of bone

BL Tian et al.

JOURNAL OF CLINICAL PATHOLOGY-MOLECULAR PATHOLOGY (2002)

Article Biochemical Research Methods

Cloning and expression in Pichia pastoris of metalloprotease domain of ADAM 9 catalytically active against fibronectin

L Schwettmann et al.

PROTEIN EXPRESSION AND PURIFICATION (2001)

Article Biochemistry & Molecular Biology

MDC-9 (ADAM-9/meltrin γ) functions as an adhesion molecule by binding the αvβ5 integrin

M Zhou et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2001)